- $1.04bn
- $18.71m
- CNY6.99bn
- 73
- 56
- 90
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 6-K | 6-K |
Standards: | USG | USG | USG | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,375 | 10,914 | 11,351 | 9,264 | 6,994 |
Cost of Revenue | |||||
Gross Profit | 1,482 | 2,268 | 1,600 | 654 | 815 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,113 | 10,189 | 11,382 | 10,090 | 7,664 |
Operating Profit | 261 | 725 | -30.2 | -826 | -669 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 567 | 1,033 | 260 | -523 | -191 |
Provision for Income Taxes | |||||
Net Income After Taxes | 471 | 856 | 204 | -547 | -205 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 468 | 884 | 583 | -548 | -205 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 468 | 884 | 583 | -548 | -205 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.02 | 3.71 | 2.41 | -2.03 | -0.237 |